University of California, San Francisco (Fresno)
Infectious Disease fellowship · Fresno, CA · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of California, San Francisco's research in infectious disease, which the program shares with other departments and affiliated hospitals.
About University of California, San Franciscoinstitution-wide infectious disease research
Infectious Disease publications from University of California, San Francisco and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
478
works per year
2nd of 71 infectious disease fellowship programs
-18.7%
2-year growth
18th of 71 infectious disease fellowship programs
30.9%
in top 10% of field (works before 2025)
13th of 67 infectious disease fellowship programs
61.2%
cited above world average
4th of 67 infectious disease fellowship programs
Works per year · * 2026 so far
Infectious Diseases · 2,250
Infectious Disease research topics at University of California, San Francisco
Papers in the window; each links to the list on OpenAlex.
- HIV/AIDS Research and Interventions 912
- Tuberculosis Research and Epidemiology 392
- SARS-CoV-2 and COVID-19 Research 298
- COVID-19 Clinical Research Studies 188
- HIV/AIDS drug development and treatment 68
- Antifungal resistance and susceptibility 61
- HIV-related health complications and treatments 58
- SARS-CoV-2 detection and testing 49
Most cited at University of California, San Francisco since 2024
All infectious disease papers there on OpenAlex
- Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA PanelRajesh Tim Gandhi et al. · JAMA · 2024 · PubMed · cited 312
- A natural experiment on the effect of herpes zoster vaccination on dementiaMarkus Eyting et al. · Nature · 2025 · PubMed · cited 262
- WHO global research priorities for antimicrobial resistance in human healthSilvia Bertagnolio et al. · The Lancet Microbe · 2024 · PubMed · cited 257
- The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodiesKyle Swanson et al. · Nature · 2025 · PubMed · cited 251
- Fibrin drives thromboinflammation and neuropathology in COVID-19Jae Kyu Ryu et al. · Nature · 2024 · PubMed · cited 118
- Plasma-based antigen persistence in the post-acute phase of COVID-19Michael J. Peluso et al. · The Lancet Infectious Diseases · 2024 · PubMed · cited 102
- The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling studyKeri N. Althoff et al. · PLoS Medicine · 2024 · PubMed · cited 85
- HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender WomenJeanne Marisa Marrazzo et al. · JAMA · 2024 · PubMed · cited 82
- Vaccine Effectiveness Against Long COVID in ChildrenHanieh Razzaghi et al. · PEDIATRICS · 2024 · PubMed · cited 73
- Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future researchTobias Broger et al. · The Lancet Global Health · 2024 · PubMed · cited 71